Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SURG vs LQDT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SURG
SurgePays, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$11M
5Y Perf.-96.4%
LQDT
Liquidity Services, Inc.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$1.12B
5Y Perf.+534.9%

SURG vs LQDT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SURG logoSURG
LQDT logoLQDT
IndustrySoftware - ApplicationSpecialty Retail
Market Cap$11M$1.12B
Revenue (TTM)$50M$480M
Net Income (TTM)$-42M$30M
Gross Margin-38.6%23.2%
Operating Margin-78.8%8.4%
Forward P/E24.3x
Total Debt$5M$14M
Cash & Equiv.$12M$175M

SURG vs LQDTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SURG
LQDT
StockMay 20May 26Return
SurgePays, Inc. (SURG)1003.6-96.4%
Liquidity Services,… (LQDT)100634.9+534.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: SURG vs LQDT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LQDT leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SURG
SurgePays, Inc.
The Specific-Use Pick

In this particular matchup, SURG is outpaced on most metrics by others in the set.

Best for: technology exposure
LQDT
Liquidity Services, Inc.
The Income Pick

LQDT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.76
  • Rev growth 31.2%, EPS growth 38.1%, 3Y rev CAGR 19.4%
  • 5.1% 10Y total return vs SURG's -99.1%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthLQDT logoLQDT31.2% revenue growth vs SURG's -55.6%
Quality / MarginsLQDT logoLQDT6.3% margin vs SURG's -83.4%
Stability / SafetyLQDT logoLQDTBeta 0.76 vs SURG's 1.30, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)LQDT logoLQDT+15.0% vs SURG's -78.9%
Efficiency (ROA)LQDT logoLQDT8.0% ROA vs SURG's -242.4%, ROIC 60.8% vs -229.7%

SURG vs LQDT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SURGSurgePays, Inc.
FY 2023
Lead Generation
100.0%$7M
LQDTLiquidity Services, Inc.
FY 2025
Product
100.0%$311M

SURG vs LQDT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLQDTLAGGINGSURG

Income & Cash Flow (Last 12 Months)

LQDT leads this category, winning 4 of 6 comparable metrics.

LQDT is the larger business by revenue, generating $480M annually — 9.5x SURG's $50M. LQDT is the more profitable business, keeping 6.3% of every revenue dollar as net income compared to SURG's -83.4%.

MetricSURG logoSURGSurgePays, Inc.LQDT logoLQDTLiquidity Service…
RevenueTrailing 12 months$50M$480M
EBITDAEarnings before interest/tax-$39M$51M
Net IncomeAfter-tax profit-$42M$30M
Free Cash FlowCash after capex-$26M$78M
Gross MarginGross profit ÷ Revenue-38.6%+23.2%
Operating MarginEBIT ÷ Revenue-78.8%+8.4%
Net MarginNet income ÷ Revenue-83.4%+6.3%
FCF MarginFCF ÷ Revenue-50.9%+16.2%
Rev. Growth (YoY)Latest quarter vs prior year+2.9%+3.7%
EPS Growth (YoY)Latest quarter vs prior year+47.2%+4.5%
LQDT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SURG leads this category, winning 3 of 3 comparable metrics.
MetricSURG logoSURGSurgePays, Inc.LQDT logoLQDTLiquidity Service…
Market CapShares × price$11M$1.1B
Enterprise ValueMkt cap + debt − cash$4M$964M
Trailing P/EPrice ÷ TTM EPS-0.23x41.67x
Forward P/EPrice ÷ next-FY EPS est.24.33x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple21.19x
Price / SalesMarket cap ÷ Revenue0.18x2.36x
Price / BookPrice ÷ Book value/share0.70x5.78x
Price / FCFMarket cap ÷ FCF19.07x
SURG leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

LQDT leads this category, winning 7 of 8 comparable metrics.

LQDT delivers a 14.2% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-10 for SURG. LQDT carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to SURG's 0.30x. On the Piotroski fundamental quality scale (0–9), LQDT scores 7/9 vs SURG's 2/9, reflecting strong financial health.

MetricSURG logoSURGSurgePays, Inc.LQDT logoLQDTLiquidity Service…
ROE (TTM)Return on equity-10.1%+14.2%
ROA (TTM)Return on assets-2.4%+8.0%
ROICReturn on invested capital-2.3%+60.8%
ROCEReturn on capital employed-177.3%+17.3%
Piotroski ScoreFundamental quality 0–927
Debt / EquityFinancial leverage0.30x0.07x
Net DebtTotal debt minus cash-$7M-$160M
Cash & Equiv.Liquid assets$12M$175M
Total DebtShort + long-term debt$5M$14M
Interest CoverageEBIT ÷ Interest expense-40.65x
LQDT leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

LQDT leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LQDT five years ago would be worth $14,784 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, LQDT leads with a +15.0% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors LQDT at 37.0% vs SURG's -49.3% — a key indicator of consistent wealth creation.

MetricSURG logoSURGSurgePays, Inc.LQDT logoLQDTLiquidity Service…
YTD ReturnYear-to-date-67.4%+22.5%
1-Year ReturnPast 12 months-78.9%+15.0%
3-Year ReturnCumulative with dividends-86.9%+157.1%
5-Year ReturnCumulative with dividends-92.8%+47.8%
10-Year ReturnCumulative with dividends-99.1%+508.2%
CAGR (3Y)Annualised 3-year return-49.3%+37.0%
LQDT leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LQDT leads this category, winning 2 of 2 comparable metrics.

LQDT is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than SURG's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LQDT currently trades 93.4% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSURG logoSURGSurgePays, Inc.LQDT logoLQDTLiquidity Service…
Beta (5Y)Sensitivity to S&P 5001.30x0.76x
52-Week HighHighest price in past year$3.45$38.83
52-Week LowLowest price in past year$0.46$21.67
% of 52W HighCurrent price vs 52-week peak+16.2%+93.4%
RSI (14)Momentum oscillator 0–10039.981.6
Avg Volume (50D)Average daily shares traded378K159K
LQDT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSURG logoSURGSurgePays, Inc.LQDT logoLQDTLiquidity Service…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$44.00
# AnalystsCovering analysts14
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+5.6%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

LQDT leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SURG leads in 1 (Valuation Metrics).

Best OverallLiquidity Services, Inc. (LQDT)Leads 4 of 6 categories
Loading custom metrics...

SURG vs LQDT: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SURG or LQDT a better buy right now?

For growth investors, Liquidity Services, Inc.

(LQDT) is the stronger pick with 31. 2% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). Liquidity Services, Inc. (LQDT) offers the better valuation at 41. 7x trailing P/E (24. 3x forward), making it the more compelling value choice. Analysts rate Liquidity Services, Inc. (LQDT) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SURG or LQDT?

Over the past 5 years, Liquidity Services, Inc.

(LQDT) delivered a total return of +47. 8%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: LQDT returned +508. 2% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SURG or LQDT?

By beta (market sensitivity over 5 years), Liquidity Services, Inc.

(LQDT) is the lower-risk stock at 0. 76β versus SurgePays, Inc. 's 1. 30β — meaning SURG is approximately 72% more volatile than LQDT relative to the S&P 500. On balance sheet safety, Liquidity Services, Inc. (LQDT) carries a lower debt/equity ratio of 7% versus 30% for SurgePays, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SURG or LQDT?

By revenue growth (latest reported year), Liquidity Services, Inc.

(LQDT) is pulling ahead at 31. 2% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: Liquidity Services, Inc. grew EPS 38. 1% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, LQDT leads at 19. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SURG or LQDT?

Liquidity Services, Inc.

(LQDT) is the more profitable company, earning 5. 9% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 5. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LQDT leads at 7. 4% versus -68. 6% for SURG. At the gross margin level — before operating expenses — LQDT leads at 43. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SURG or LQDT?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SURG or LQDT better for a retirement portfolio?

For long-horizon retirement investors, Liquidity Services, Inc.

(LQDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), +508. 2% 10Y return). Both have compounded well over 10 years (LQDT: +508. 2%, SURG: -99. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SURG and LQDT?

These companies operate in different sectors (SURG (Technology) and LQDT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SURG is a small-cap quality compounder stock; LQDT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SURG

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 145%
Run This Screen
Stocks Like

LQDT

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SURG and LQDT on the metrics below

Revenue Growth>
%
(SURG: 291.6% · LQDT: 3.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.